Center-Authored Papers

Filters: Author is Disis, Mary L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H.  2014.  Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.. Innate immunity. 20(8):857-66. Abstract
W
Weber JS, Yang JC, Atkins MB, Disis ML.  2015.  Toxicities of Immunotherapy for the Practitioner.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Watt WC, Cecil DL, Disis ML.  2016.  Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.. Seminars in immunopathology. Abstract
S
Stanton SE, Disis ML.  2015.  Designing vaccines to prevent breast cancer recurrence or invasive disease.. Immunotherapy. 7(2):69-72.
Stanton SE, Disis ML.  2016.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer.. Journal for immunotherapy of cancer. 4:59. Abstract
Stanton SE, Eary JF, Marzbani EA, Mankoff D, Salazar LG, Higgins D, Childs J, Reichow J, Dang Y, Disis ML.  2016.  Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo.. Journal for immunotherapy of cancer. 4:27. Abstract
Stanton SE, Adams S, Disis ML.  2016.  Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.. JAMA oncology. Abstract
Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP et al..  2016.  Leveraging premalignant biology for immune-based cancer prevention.. Proceedings of the National Academy of Sciences of the United States of America. 113(39):10750-8. Abstract
Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M et al..  2017.  Precancer Atlas to Drive Precision Prevention Trials.. Cancer research. 77(7):1510-1541. Abstract
Scott CS, Nagasawa PR, Abernethy NF, Ramsey BW, Martin PJ, Hacker BM, Schwartz HD, Brock DM, Robins LS, Wolf FM et al..  2013.  Expanding Assessments of Translational Research Programs: Supplementing Metrics With Value Judgments.. Evaluation & the health professions. Abstract
Salazar LG, Lu H, Reichow JL, Childs JS, Coveler AL, Higgins DM, Waisman J, Allison KH, Dang Y, Disis ML.  2017.  Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.. JAMA oncology. Abstract
R
Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ et al..  2016.  The Human Vaccines Project: A roadmap for cancer vaccine development.. Science translational medicine. 8(334):334ps9. Abstract
P
Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al..  2011.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(12):1539-46. Abstract
Paulson KG, Tegeder A, Willmes C, Iyer JG, Afanasiev OK, Schrama D, Koba S, Thibodeau R, Nagase K, Simonson WT et al..  2014.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.. Cancer immunology research. 2(11):1071-9. Abstract
Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.  2016.  Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.. Oncotarget. Abstract
Patel A, Kaufman HL, Disis ML.  2017.  Next generation approaches for tumor vaccination.. Chinese clinical oncology. 6(2):19. Abstract
M
Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HE, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC et al..  2018.  A First-in-Human Phase 1 Study of Subcutaneous Outpatient Recombinant Human IL-15 (rhIL-15) in Adults with Advanced Solid Tumors.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(7):1525-1535. Abstract
Marzbani E, Inatsuka C, Lu H, Disis ML.  2013.  The invisible arm of immunity in common cancer chemoprevention agents.. Cancer prevention research (Philadelphia, Pa.). 6(8):764-73. Abstract
Marquez JP, Stanton SE, Disis ML.  2015.  The Antigenic Repertoire of Premalignant and High-Risk Lesions.. Cancer prevention research (Philadelphia, Pa.). 8(4):266-270. Abstract
Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E et al..  2014.  Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.. Journal of translational medicine. 12(1):121. Abstract
L
Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML.  2012.  Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera.. Cancer prevention research (Philadelphia, Pa.). Abstract
Liao JB, Swensen RE, Ovenell KJ, Hitchcock-Bernhardt KM, Reichow JL, Apodaca MC, D'Amico L, Childs JS, Higgins DM, Buening BJ et al..  2017.  Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer.. Gynecologic oncology. Abstract
Liao JB, Ovenell KJ, Curtis EEM, Cecil DL, Koehnlein MR, Rastetter LR, Gad EA, Disis ML.  2015.  Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer.. Journal for immunotherapy of cancer. 3:16. Abstract
Liao JB, Disis ML.  2013.  Therapeutic vaccines for ovarian cancer.. Gynecologic oncology. Abstract
Li ZY, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem H-P, Disis ML et al..  2009.  Toward a stem cell gene therapy for breast cancer.. Blood. 113(22):5423-33. Abstract